Besides this, random survival forest analysis identified a prognostic signature that is the weighted composition of expression values of three ncRNAs, namely LOC441179, PON2 and USP46‐AS1, that could accurately separate glioma samples with longer OS from those with shorter OS. This evidence concerns the gene PON2 and glioma.